Active Ingredient History
Levonorgestrel is a hormonal medication which is used in a number of birth control methods. It is combined with an estrogen to make combination birth control pills. As an emergency birth control, sold under the brand name Plan B One-Step among others, it is useful within 72 hours of unprotected sex. The more time that has passed since sex, the less effective the medication becomes, and it does not work after pregnancy (implantation) has occurred. Levonorgestrel works by preventing ovulation or fertilization from occurring. It decreases the chances of pregnancy by 57 to 93%. In an intrauterine device (IUD), such as Mirena among others, it is effective for the long-term prevention of pregnancy. A levonorgestrel-releasing implant is also available in some countries. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenomyosis (Phase 2)
Affect (Phase 4)
Anti-Infective Agents (Phase 1)
Anti-Retroviral Agents (Phase 2)
Art (Phase 4)
Biological Availability (Phase 1)
Breast Feeding (Phase 4)
Contraception (Phase 4)
Contraception Behavior (Phase 1)
Contraception, Postcoital (Phase 2/Phase 3)
Contraceptive Agents (Phase 4)
Diabetes Mellitus, Type 2 (Phase 1)
Drug Interactions (Phase 1)
Endometrial Hyperplasia (Phase 3)
Healthy Volunteers (Phase 2)
Hematologic Neoplasms (Phase 1)
Hemorrhage (Phase 1/Phase 2)
Hepatitis B, Chronic (Phase 1)
HIV (Phase 4)
HIV Infections (Phase 2)
Inflammation (Phase 4)
Leiomyoma (Phase 4)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Men (Phase 2)
Menorrhagia (Phase 4)
Menstrual Cycle (Phase 2)
Migraine Disorders (Phase 3)
Multiple Sclerosis (Phase 1)
Neoplasms (Phase 1)
Neural Analyzers (Phase 4)
Non-alcoholic Fatty Liver Disease (Phase 1)
Pharmacokinetics (Phase 1/Phase 2)
Postpartum Period (Phase 4)
Pregnancy (Early Phase 1)
Pregnancy Complications (Phase 3)
Scleroderma, Systemic (Phase 1)
Therapeutic Equivalency (Phase 1)
Tuberculosis (Phase 2)
Uterine Diseases (Phase 4)
Women (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue